PDF-Lloyd Klickstein, MD, PhD on behalf of the Novartis/GenVec/KUMC RAC me

CGF166 Atonal Gene Therapy for Hearing Loss Vestibular DysfunctionReview of NIH OBA protocol 1310 CGF166 RAC Meeting December 4 2013 CGF166 Team Attendees NovartisTeam MemberFunctionLocationR. Novartis Institute for Biomedical Research – francois.pognan@novartis.com Wellcome Trust Genome Campus – Hinxton 29 - 30 September 2014 The eTOX consortium: of the art of sharing the Presented by: Wm. Mark Woodall. Introduction. “The future . ain’t. what it used to be” – Former New York Yankee Manager and Hall of Famer Yogi Berra. The present Insurance Industry market place will look quite different in the years to come. The creative and adaptive will survive, the weak will have expense ratios that will be unsustainable.. 2013 ISPE- NJ Supplier Showcase, September 12. Environmental Sustainability at Novartis. Expanding access to healthcare. R&D for rare and . neglected diseases . Malaria . Initiative . Leprosy elimination. involved. ? What are your r. esponsibilities?. May 2013: Research Institute, Clinical Research Administration. Investigational New Drug Application (IND). Definition of IND. R. oles . and . Responsibilities . Pharma SMEs in the current Patent regime. Deepak Padia. Managing Director – Octavius Pharma Pvt. Ltd.. Current Issues. Awareness about Patents. Knowledge of Prior Art. Opportunities for SMEs. Selection of Right Product. Outset, Inc.2460 Galpin Court, Suite #110Chanhassen, MN 55317(888) MYOUTSEToutsetinc.comChanhassen, Minn — March 6, 2007 — Outset’s new FLEX Grill Basket’s unique grid construction 2013 ISPE- NJ Supplier Showcase, September 12. Environmental Sustainability at Novartis. Expanding access to healthcare. R&D for rare and . neglected diseases . Malaria . Initiative . Leprosy elimination. TheValidatedInvestigatorGlobalAssessmentforAtopicDermatitis(vIGA-AD):ThedevelopmentandreliabilitytestingofanovelclinicaloutcomemeasurementinstrumentfortheseverityofatopicdermatitisEricSimpson,MD,Rober PDFA | 1/22/09 1 The HR office enforces policies and procedures related to employee appeals, attendance, disciplinary actions, drug-alcohol policy, ethics, grievances, non-reappointment, whistleblow DUPI PROJECTP&I underwrites on behalf of:Lloyd’s Syndicates (S&P A+)CNA Hardy 382; Navigators 1221; Hiscox 33; Talbot 1183; Novae 2007; Ascot 1414; Atrium 609;Arch 2012: AXIS 1686; O’Farrel (see pages 2 & 3) (see pages 5, 6 & 7) Please take a moment to look at the new space layout on the following pages. You can also learn about the PELA EURETINA Novartis Pharma AG Forum 1 Novartis Campus 4056Basel Switzerland GLO/LUC/0120aj 2014 Novartis Pharma AGSeptember2014XOVA Q AAbout the XOVA programWhat is the XOVAprogramThe eXcellence in Oph EURETINA 2014 EventNovartis Pharma AG Forum 1 Novartis Campus 4056Basel Switzerland GLO/LUC/0120al 2014 Novartis Pharma AGAugust 2014Winning Organizations2014Uday R Gajiwala Door-to-door screening for The Sino-US Advanced Healthcare Professional Exchange Program. Kimberly Connelly, MAT. Senior International Officer. Office of International Programs, University of Kansas Medical Center. Robert M. Klein, PhD, FAAA.